EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Recent progress in the treatment of hematological malignancies. III. Acute leukemia--bone marrow transplantation



Recent progress in the treatment of hematological malignancies. III. Acute leukemia--bone marrow transplantation



Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 78(6): 789-791




(PDF 0-2 workdays service: $29.90)

Accession: 041185543

Download citation: RISBibTeXText

PMID: 2677177



Related references

Recent progress in the treatment of hematological malignancies. II. Acute lymphoblastic leukemia (ALL). Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 78(6): 769-773, 1989

Recent progress in the treatment of hematological malignancies II. Acute nonlymphocytic leukemia in adult. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 78(6): 765-768, 1989

Recent progress in the treatment of hematological malignancies. III. Acute leukemia--treatment with cytokines. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 78(6): 781-784, 1989

Recent progress in the treatment of hematological malignancies. II. Chemotherapy of relapsed and refractory acute myeloid leukemia in adult. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 78(6): 774-780, 1989

Allogeneic bone marrow transplantation for hematological malignancies--controversies and recent advances. Acta Oncologica 36(6): 549-564, 1997

Recent progress in the treatment of hematological malignancies. IV. Chronic myelocytic leukemia. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 78(6): 792-795, 1989

Bone marrow transplantation from donors other than HLA matched siblings for hematological malignancies. Nagoya Bone Marrow Transplantation Group and Tokai Marrow Donor Bank. Japanese Journal of Clinical Hematology 35(8): 729-737, 1994

Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide. Best Practice & Research. Clinical Haematology 24(3): 359-368, 2012

Bone marrow transplantation in the treatment of hematological malignancies and solid tumors. Wiener Klinische Wochenschrift 99(2): 49-53, 1987

Treatment of hematological malignancies relapsing after allogeneic bone marrow transplantation. Blood Reviews 8(4): 234-240, 1994

Successful treatment of hematological and extramedullary relapse of MLL-positive acute lymphoblastic leukemia after bone marrow transplantation using donor leukocyte infusion. Annals of Hematology 83(10): 667-669, 2004

Allogenic bone marrow transplantation versus autologous bone marrow transplantation for the treatment of childhood acute lymphoblastic leukemia in second remission after early marrow relapse. Blood 86(10 SUPPL 1): 939A, 1995

Bone marrow transplantation in the treatment of hematological malignancies and solid tumors The Innsbruck experience. Annals of Hematology 65(SUPPL ): A12, 1992

Use of recombinant human interleukin 2 in conjunction with bone marrow transplantation as a model for control of minimal residual disease in malignant hematological disorders i. treatment of murine leukemia in conjunction with allogeneic bone marrow transplantation and il 2 activated cell mediated immunotherapy. Cancer Investigation 10(1): 19-26, 1992